Drug to treat agitation in Alzheimer’s patients approved in Canada

Thanks! Share it with your friends!

You disliked this video. Thanks for the feedback!

Added by XaniaNews
17 Views
Health Canada has green lit a drug previously approved for schizophrenia and depression to treat symptoms of agitation in Alzheimer’s patients – a common symptom of the disease.

Rexulti (brexpiprazole) oral tablets manufactured by Otsuka Pharmaceutical Canada Inc. and Lundbeck Canada Inc. were issued a Notice of Compliance by the regulator, according to a company release Wednesday.

This approval was given after three 12-week randomized, double-blind, placebo-controlled studies, the release said. Global's Katherine Ward explains.

For more info, please go to https://globalnews.ca/news/10249782/alzheimers-agitation-symptoms-canada-drug-approval/

Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#Health #Alzheimers #Dementia
Category
News and politics
Tags
global news, health news, health

Post your comment

Comments

Be the first to comment

Related Articles